Fernando Mateus - 18 Feb 2022 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role: SENIOR VICE PRESIDENT
Signature: /s/ Fernando Mateus by Jessica H. Paik, Attorney-in-Fact
Issuer symbol: ABT
Transactions as of: 18 Feb 2022
Net transactions value: -$254,836
Form type: 4
Filing time: 23 Feb 2022, 19:21:50 UTC
Previous filing: 08 Dec 2021
Next filing: 27 Jul 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ABT	Common shares without par value	Award	$0	+10,482	+121%	$0.000000	19,142	18 Feb 2022	Direct	F1
transaction	ABT	Common shares without par value	Tax liability	$69,490	-595	-3.1%	$116.79	18,547	19 Feb 2022	Direct
transaction	ABT	Common shares without par value	Tax liability	$81,870	-701	-3.8%	$116.79	17,846	21 Feb 2022	Direct
transaction	ABT	Common shares without par value	Tax liability	$103,476	-886	-5%	$116.79	16,960	22 Feb 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ABT	Option (right to buy)	Award	$0	+48,852		$0.000000	48,852	18 Feb 2022	Common Shares	48,852	$117.58	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
F2	Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 16,284 on February 18, 2023, 16,284 on February 18, 2024, and 16,284 on February 18, 2025.